Hampton RY |
Genetic analysis of hydroxymethylglutaryl-coenzyme A reductase regulated degradation. |
1998 |
Curr. Opin. Lipidol. |
pmid:9559264
|
Aharonson Z et al. |
Stringent structural requirements for anti-Ras activity of S-prenyl analogues. |
1998 |
Biochim. Biophys. Acta |
pmid:9545527
|
Desrosiers RR and Béliveau R |
Regulation by GTPgammaS of protein carboxylmethyltransferase activity in kidney brush border membranes. |
1998 |
Arch. Biochem. Biophys. |
pmid:9514644
|
Ura H et al. |
Selective cytotoxicity of farnesylamine to pancreatic carcinoma cells and Ki-ras-transformed fibroblasts. |
1998 |
Mol. Carcinog. |
pmid:9496909
|
Roullet JB et al. |
Inhibition of Ca2+ uptake into A7r5 vascular smooth muscle cells by farnesol: lack of effect on membrane fluidity and Ca2+-ATPase activities. |
1997 |
J. Hypertens. |
pmid:9488229
|
Haklai R et al. |
Dislodgment and accelerated degradation of Ras. |
1998 |
Biochemistry |
pmid:9477957
|
Roullet JB et al. |
Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells. |
1997 |
J. Biol. Chem. |
pmid:9405427
|
Ghosh PM et al. |
Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. |
1997 |
Biochim. Biophys. Acta |
pmid:9398081
|
Goossens A and Merckx L |
Allergic contact dermatitis from farnesol in a deodorant. |
1997 |
Contact Derm. |
pmid:9385513
|
Gana-Weisz M et al. |
The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9367867
|